Journal for ImmunoTherapy of Cancer

Published by BMJ Publishing Group

Open access · CC BY-NC-ND · In DOAJ · United Kingdom · Cancer Immunotherapy and Biomarkers

Journal at a glance

ISSN

2051-1426

Publisher

BMJ Publishing Group

Country

United Kingdom

Language

en

License

CC BY-NC-ND

Also known as: J Immunother Cancer (Abbreviation), JITC (Alternate title)

Indexing

• Web of Science (SCIE): Indexed
• Scopus: Indexed
• DOAJ: Active
• Medline: Active
• Pubmed: Active

Metrics

Subjects

• Cancer Immunotherapy and Biomarkers
• Immunotherapy and Immune Responses
• CAR-T cell therapy research
• Immune Cell Function and Interaction
• Immune cells in cancer
• Monoclonal and Polyclonal Antibodies Research
• Virus-based gene therapy research
• Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
• Internal medicine

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• TGF-β1 drives neutrophil extracellular traps formation to promote CD8 + T cell exhaustion via the ERK-c-Fos-JunB axis, mediating gastric cancer immunotherapy resistance (2026)
• Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias (2026)
• “Yong” syndrome–cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer (2026)
• β-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma (2026)
• Loss of NCCRP1 overcomes immune evasion in lung adenocarcinoma (2026)

Similar journals

• ImmunoTargets and Therapy — New Zealand · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total, Same language
• Journal of Immunotherapy — United States · — · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total
• Frontiers in Immunology — Switzerland · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same language
• JCI Insight — United States · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same language
• Molecular Therapy: Oncology — Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same language
• Immuno — Switzerland · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total, Same language

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate), Scopus · Last verified 2026-09-05

Journal homepage · Author guidelines